Research shows promising results for a weekly injectable Parkinson's treatment that maintains consistent medication levels, possibly eliminating multiple daily pills.

Stimvia announced that it completed a clinical study of its peroneal electrical transcutaneous neurmodulation (peroneal eTNM) ...

The phase IIb PADOVA study evaluated the safety and efficacy of prasinezumab versus placebo in 586 randomized patients with early-stage Parkinson’s disease who were on stable symptomatic treatment.

Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease - Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of ...

Ventyx says Parkinson’s disease drug hit main goal in small mid-stage trial Jun. 17, 2025 7:48 AM ET Ventyx Biosciences, Inc. (VTYX) Stock By: Dulan Lokuwithana, SA News Editor 2 Comments Play ...

Changes in the bacteria found in the mouth and gut of Parkinson’s disease patients could act as an early warning sign that their symptoms are worsening, new research suggests. Scientists, using ...

Changes in the bacteria found in the mouth and gut of Parkinson’s disease patients could act as an early warning sign that their symptoms are worsening, new research suggests. Scientists, using ...

Parkinson’s disease has always been hard to study, due to the fact that it develops slowly, over many years, and is difficult to diagnose in the earlier stages.

We've already seen a pen that helps people with Parkinson's disease to write clearly, but this one is a little different. By ...